Aliases & Classifications for Skin Conditions

MalaCards integrated aliases for Skin Conditions:

Name: Skin Conditions 37 40
Dermatologic Disorders 69

Classifications:



Summaries for Skin Conditions

MedlinePlus : 40 Your skin is your body's largest organ. It covers and protects your body. Your skin Holds body fluids in, preventing dehydration Keeps harmful microbes out, preventing infections Helps you feel things like heat, cold, and pain Keeps your body temperature even Makes vitamin D when the sun shines on it Anything that irritates, clogs, or inflames your skin can cause symptoms such as redness, swelling, burning, and itching. Allergies, irritants, your genetic makeup, and certain diseases and immune system problems can cause rashes, hives, and other skin conditions. Many skin problems, such as acne, also affect your appearance. NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases

MalaCards based summary : Skin Conditions, also known as dermatologic disorders, is related to contact dermatitis and dermatitis, and has symptoms including nasal itching, dry skin and skin manifestations. An important gene associated with Skin Conditions is IL1A (Interleukin 1 Alpha), and among its related pathways/superpathways are Toll-Like receptor Signaling Pathways and T cell receptor signaling pathway. The drugs Chlorhexidine and Tacrolimus have been mentioned in the context of this disorder. Affiliated tissues include skin, breast and testes.

Related Diseases for Skin Conditions

Diseases related to Skin Conditions via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 114)
# Related Disease Score Top Affiliating Genes
1 contact dermatitis 29.5 IL1A TNF
2 dermatitis 10.8
3 darier-white disease 10.5
4 erythroderma, ichthyosiform, congenital reticular 10.5
5 nevoid hypermelanosis, linear and whorled 10.5
6 dowling-degos disease 10.5
7 scleredema 10.5
8 transient bullous dermolysis of the newborn 10.4
9 erythrokeratodermia variabilis et progressiva 1 10.4
10 skin creases, congenital symmetric circumferential, 1 10.4
11 nail disorder, nonsyndromic congenital, 1 10.4
12 benign chronic pemphigus 10.4
13 pityriasis rubra pilaris 10.4
14 porokeratosis 1, multiple types 10.4
15 rothmund-thomson syndrome 10.4
16 restrictive dermopathy, lethal 10.4
17 wiskott-aldrich syndrome 10.4
18 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 10.4
19 ichthyosis, x-linked 10.4
20 vitiligo-associated multiple autoimmune disease susceptibility 1 10.4
21 neutrophilic dermatosis, acute febrile 10.4
22 crouzon syndrome with acanthosis nigricans 10.4
23 psoriasis 14, pustular 10.4
24 achondroplasia, severe, with developmental delay and acanthosis nigricans 10.4
25 granuloma annulare 10.4
26 erythema multiforme 10.4
27 borderline leprosy 10.4
28 junctional epidermolysis bullosa 10.4
29 palmoplantar keratosis 10.4
30 necrobiosis lipoidica 10.4
31 porokeratosis 10.4
32 inverted follicular keratosis 10.4
33 scabies 10.4
34 dermatitis herpetiformis 10.4
35 seborrheic dermatitis 10.4
36 rosacea 10.4
37 pityriasis versicolor 10.4
38 acquired generalized lipodystrophy 10.4
39 aquagenic pruritus 10.4
40 erythema nodosum, idiopathic 10.4
41 gianotti crosti syndrome 10.4
42 giant congenital nevus 10.4
43 granulomatous rosacea 10.4
44 grover's disease 10.4
45 guttate psoriasis 10.4
46 hydroa vacciniforme 10.4
47 keratosis follicularis spinulosa decalvans 10.4
48 linear porokeratosis 10.4
49 localized lipodystrophy 10.4
50 lymphocytic infiltrate of jessner 10.4

Graphical network of the top 20 diseases related to Skin Conditions:



Diseases related to Skin Conditions

Symptoms & Phenotypes for Skin Conditions

UMLS symptoms related to Skin Conditions:


nasal itching, dry skin, skin manifestations, pruritus, exanthema, enanthema

Drugs & Therapeutics for Skin Conditions

Drugs for Skin Conditions (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1348)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 55-56-1 2713 9552079
2
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 104987-11-3 445643 439492
3
Metformin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 657-24-9 4091 14219
4
Acitretin Approved Phase 4,Phase 3,Phase 2 55079-83-9 5284513 6437841
5
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1994-09-7, 94-09-7 2337
6
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 64-17-5 702
7
Petrolatum Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 8009-03-8
8 Titanium dioxide Approved Phase 4,Phase 2 13463-67-7
9
Ustekinumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 815610-63-0
10
Desonide Approved, Investigational Phase 4,Phase 3 638-94-8 5311066
11
Esomeprazole Approved, Investigational Phase 4,Phase 1 161796-78-7, 119141-88-7 9579578 4594
12
Etanercept Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 185243-69-0
13
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
14
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 22916-47-8 4189
15
Adalimumab Approved Phase 4,Phase 3,Phase 2,Phase 1 331731-18-1 16219006
16
Infliximab Approved Phase 4,Phase 3,Phase 2,Phase 1 170277-31-3
17
Ciclopirox Approved, Investigational Phase 4,Phase 3 29342-05-0 2749
18
Phenol Approved, Experimental Phase 4 108-95-2 996
19
Clindamycin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 18323-44-9 29029
20
Clobetasol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 25122-41-2, 25122-46-7 5311051 32798
21
Glycerol Approved, Investigational Phase 4,Phase 3,Phase 1 56-81-5 753
22
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 124-94-7 31307
23
Aminolevulinic acid Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 106-60-5 137
24
Isotretinoin Approved Phase 4,Phase 3,Phase 2,Phase 1 4759-48-2 5282379 5538
25
Salicylic acid Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 69-72-7 338
26
Fexofenadine Approved, Investigational Phase 4,Phase 2 83799-24-0 3348
27
Gabapentin Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 60142-96-3 3446
28
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 51-45-6, 75614-87-8 774
29
Pregabalin Approved, Illicit, Investigational Phase 4 148553-50-8 5486971
30
Imiquimod Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 99011-02-6 57469
31
Alginic acid Approved, Experimental, Investigational Phase 4,Phase 3 9005-32-7
32
Benzoyl peroxide Approved Phase 4,Phase 3,Phase 1,Phase 2 94-36-0 7187
33
Bosentan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 147536-97-8 104865
34
Hydroquinone Approved, Investigational Phase 4,Phase 3,Phase 2 123-31-9 785
35
Acetylcholine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-84-3 187
36
Menthol Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 2216-51-5 16666
37
Zinc Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 7440-66-6 32051 23994
38
Zinc oxide Approved Phase 4,Phase 3,Phase 2 1314-13-2
39
Pimecrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 137071-32-0 17753757 6447131
40
Azelaic acid Approved Phase 4,Phase 2,Phase 3,Phase 1 123-99-9 2266
41
Iron Approved Phase 4,Phase 3,Phase 2,Early Phase 1 7439-89-6 23925
42
Iodine Approved, Investigational Phase 4,Phase 2,Phase 1,Early Phase 1 7553-56-2 807
43
Povidone Approved Phase 4,Phase 3,Phase 2 9003-39-8
44
Povidone-iodine Approved Phase 4,Phase 3 25655-41-8
45
Bacitracin Approved, Vet_approved Phase 4,Phase 3,Phase 2 1405-87-4 10909430 439542
46
Hydrocortisone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 50-23-7 657311 5754
47 Parthenolide Approved, Investigational Phase 4,Phase 3,Phase 2 20554-84-1
48
Carboplatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 41575-94-4 10339178 38904 498142
49
Epirubicin Approved Phase 4,Phase 3,Phase 2,Phase 1 56420-45-2 41867
50
Paclitaxel Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 33069-62-4 36314

Interventional clinical trials:

(show top 50) (show all 10000)

# Name Status NCT ID Phase Drugs
1 Effect of Chlorhexidine Skin Cleansing on Skin Flora Unknown status NCT00198679 Phase 4 Chlorhexidine
2 Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo Unknown status NCT01333410 Phase 4 tacrolimus ointment;Mometasone furoate
3 Study of Efficacy of Metformin in the Treatment of Acanthosis Nigricans in Children With Obesity Unknown status NCT02438020 Phase 4 Metformin
4 Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects? Unknown status NCT01228409 Phase 4 Acitretin 17.5 mg/day
5 Weight Reduction Alone May Not be Sufficient to Maintain Disease Remission in Obese Patients With Psoriasis Unknown status NCT01439425 Phase 4
6 Mometasone Furoate Cream Reduces Acute Radiation Dermatitis in Head and Neck Squamous Cell Carcinomas' Patients Unknown status NCT02495064 Phase 4 Mometasone Furoate Cream
7 The Difference of Microparticles in Patients With Psoriasis Vulgaris Who Received Stelara(Ustekinumab) Unknown status NCT02693470 Phase 4 Ustekinumab
8 Proton Pump Inhibitors Use in Patients With Psoriasis Unknown status NCT02624544 Phase 4 esomeprazole;desonide
9 Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate Unknown status NCT02313922 Phase 4 etanercept combined with methotrexate or etanercept combined with placebo
10 Quality of Life of Patients With Psoriasis Treated With Methotrexate: Prospective, Randomized, Double-blind, Parallel Group Study. Unknown status NCT02248792 Phase 4 Methotrexate
11 Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis Unknown status NCT02144857 Phase 4 etanercept;ustekinumab;cyclosporine
12 A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis Unknown status NCT01558310 Phase 4 Ustekinumab;Placebo
13 Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2 Unknown status NCT01443338 Phase 4 Triptergium Wilfordii;Acitretin
14 Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors Therapy Unknown status NCT01237262 Phase 4 Adalimumab, etanercept, infliximab
15 An Open-label Study to Evaluate the Efficacy of Re-treatment for Patients With a History of Etanercept Use Unknown status NCT01132235 Phase 4
16 Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque Psoriasis Unknown status NCT00707070 Phase 4 efalizumab plus placebo;efalizumab plus acitretin
17 Home UVB Phototherapy for Psoriasis: Effectiveness, Quality of Life and Cost-Effectiveness Unknown status NCT00150930 Phase 4
18 Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis Unknown status NCT01014637 Phase 4 Amorolfine (Antifungal);RV4104A, Ciclopiroxolamine, Cyclopirox (Keratolytic Agents/Antifungal)
19 Epidermal Grafting in Wound Healing Unknown status NCT02535481 Phase 4
20 Effectiveness of Lavage With Alcohol - Chlorhexidine for Chemical Matricectomy Unknown status NCT01844141 Phase 4 70% alcohol;70% alcohol - 0.5% clorhexidine
21 Efficacy & Safety of Clindamycin and Tretinoin in Acne Unknown status NCT01111994 Phase 4 Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel
22 Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation Unknown status NCT00779792 Phase 4 clobetasol;triamcinolone acetonide;tacrolimus;glycerol;vehicle ointment (paraffin oil/soft white paraffin)
23 Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate Unknown status NCT01491711 Phase 4 Methylaminolevulinate PDT in 2 sessions;Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT
24 Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea Unknown status NCT01139749 Phase 4 oral isotretinoin;salicylic acid and ciclopirox olamine
25 Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel Unknown status NCT02647151 Phase 4 METHYLAMINOLEVULINATE HYDROCHLORIDE;AMINOLEVULINIC ACID HYDROCHLORIDE
26 Pregabalin for the Treatment of Uremic Pruritus Unknown status NCT01852318 Phase 4 pregabalin 75mg daily for 12 weeks;fexofenadine 60 mg daily for 12 weeks;placebo
27 Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis Unknown status NCT01656226 Phase 4
28 Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis Unknown status NCT01413763 Phase 4 Imiquimod cream 3.75%;Placebo cream
29 Efficacy of Pregabalin in the Management of Chronic Uremic Pruritus Unknown status NCT01073501 Phase 4 Pregabalin;Placebo
30 Leptospermum Scoparium Honey and Wound Care for Pressure Ulcers Unknown status NCT02689310 Phase 4
31 Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris Unknown status NCT01448733 Phase 4 Benzoyl peroxide 2.5%/clindamycin phosphate 1.2% in the morning with with tretinoin 0.05% gel in the evening
32 A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne Unknown status NCT01422785 Phase 4 clindamycin phosphate 1.2%/tretinoin 0.025% gel alone;clindamycin phosphate 1.2%/tretinoin 0.025% gel plus benzoyl peroxide 6% foaming cloths
33 The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis Unknown status NCT02480335 Phase 4 bosentan
34 Clinical Study to Evaluate the Efficacy of Topical Medications Containing Benzoyl Peroxide and Sulfur in the Regression in the Short Time (24 Hours) of Moderate Acne Vulgaris Grade II (Pimples) Unknown status NCT01260571 Phase 4 Benzoyl peroxide and sulfur
35 Efficacy of Quantum NPWT With Simultaneous Irrigation on Reduction of Wound Volume in Stage III/IV Pressure Ulcers. Unknown status NCT01734109 Phase 4
36 Clinical Trial of Hydroquinone Versus Miconazol in Melasma Unknown status NCT01661556 Phase 4 Miconazole;Hydroquinone
37 Olive Oil's Cream Effectiveness in Prevention of Pressure Ulcers in Immobilized Patients in Primary Care Unknown status NCT01595347 Phase 4 Hyper-oxigenated fatty acid
38 Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer Unknown status NCT01459666 Phase 4 Dysport (abobotulinumtoxinA);Bacteriostatic 0.9% Sodium Chloride (vehicle)
39 Trial Comparing Calmoseptine Ointment and Desitin Diaper Rash Paste in Diaper Dermatitis in Neonates and Infants Unknown status NCT02716415 Phase 4 Calmoseptine Ointment;Destin Maximum Strength 40% Zinc
40 Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo Unknown status NCT01246921 Phase 4 Fluticasone proprionate 0.05% cream
41 Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis) Unknown status NCT01082393 Phase 4 topical tacrolimus treatment;topical pimecrolimus treatment;local mometasone furoate treatment;cold cream
42 Azelaic Acid Versus Hydroquinone in Melasma Unknown status NCT00927771 Phase 4 azelaic acid gel;hydroquinone cream
43 Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses Unknown status NCT01229319 Phase 4 Cryotherapy alone to Left arm plus cryotherapy + imiquimod to Right arm;Cryotherapy alone to Left arm plus cryotherapy + imiquimod to Right arm
44 Sienna+® Injection Time Study 4 Arms Unknown status NCT02612870 Phase 4
45 Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodine Unknown status NCT02479347 Phase 4 Chlorhexidine;Povidone-Iodine
46 Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents Unknown status NCT01797562 Phase 4 T.R.U.E. Test Panel 3.2
47 Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer Unknown status NCT02207361 Phase 4 Paclitaxel, Carboplatin;Paclitaxel, Epirubicin
48 Weekly and Every 3 Week Administration of Paclitaxel Liposome Injection in Metastatic Breast Cancer Unknown status NCT02142790 Phase 4 paclitaxel liposome injection
49 Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia Unknown status NCT01111981 Phase 4 Clobetasol Propionate 0.05% Emollient Foam
50 Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis Unknown status NCT01956409 Phase 4 18F-FCH;Magnevist

Search NIH Clinical Center for Skin Conditions

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Skin Conditions cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Skin Conditions:
BioDFactor
Stemedyne
Embryonic/Adult Cultured Cells Related to Skin Conditions:
Bone marrow-derived mesenchymal stem cells (Stemedyne PMIDs: 23295150

Genetic Tests for Skin Conditions

Anatomical Context for Skin Conditions

MalaCards organs/tissues related to Skin Conditions:

38
Skin, Breast, Testes, Lymph Node, Bone, Brain, T Cells

Publications for Skin Conditions

Articles related to Skin Conditions:

(show top 50) (show all 107)
# Title Authors Year
1
A Randomized Controlled Trial Determining Variances in Ostomy Skin Conditions and the Economic Impact (ADVOCATE Trial). ( 29300287 )
2018
2
Millimeter-wave emissivity as a metric for the non-contact diagnosis of human skin conditions. ( 28836682 )
2017
3
Patient-centred health care for people with chronic skin conditions. ( 28833008 )
2017
4
Common Skin Conditions in Children: Congenital Melanocytic Nevi and Infantile Hemangiomas. ( 28196319 )
2017
5
Common Skin Conditions in Children: Noninfectious Rashes. ( 28196317 )
2017
6
The role of adult attachment orientation and coping in psychological adjustment to living with skin conditions. ( 29274241 )
2017
7
CMS MDS 3.0 Section M Skin Conditions in Long-term Care: Pressure Ulcers, Skin Tears, and Moisture-Associated Skin Damage Data Update. ( 28817452 )
2017
8
Compassion focussed self-help for skin conditions in individuals with insecure attachment: A pilot evaluation of the acceptability and potential effectiveness. ( 28869774 )
2017
9
Nutritional Status and Habitual Dietary Intake Are Associated with Frail Skin Conditions in Community-Dwelling Older People. ( 28112767 )
2017
10
Dry skin conditions are related to the recovery rate of skin temperature after cold stress rather than to blood flow. ( 27917468 )
2017
11
Common Skin Conditions in Children: Neonatal Skin Lesions. ( 28196316 )
2017
12
Effects of intake of Lactobacillus casei subsp. casei 327 on skin conditions: a randomized, double-blind, placebo-controlled, parallel-group study in women. ( 28748132 )
2017
13
Associations between skin barrier characteristics, skin conditions and health of aged nursing home residents: a multi-center prevalence and correlational study. ( 29132305 )
2017
14
Context for Practice: Clinical Challenges Related to Rare and Uncommon Skin Conditions. ( 28682852 )
2017
15
No-rinse mousse shampoos for skin conditions in dogs and cats. ( 28694380 )
2017
16
Application of three hygrometers under different skin conditions in dogs: dry, moist and haired skin. ( 28868812 )
2017
17
The impact of skin conditions on generic health-related quality of life. ( 28504391 )
2017
18
The Potential Psychological Impact of Skin Conditions. ( 28150109 )
2017
19
The cutaneous ecosystem: the roles of the skin microbiome in health and its association with inflammatory skin conditions in humans and animals. ( 28133874 )
2017
20
Amelioration of atopic-like skin conditions in NC/Tnd mice by topical application with distilled Alpinia intermedia Gagnep extracts. ( 28815692 )
2017
21
CMS MDS 3.0 Section M Skin Conditions in Long-term Care: Pressure Ulcers, Skin Tears, and Moisture-Associated Skin Damage Data Update. ( 28817454 )
2017
22
Inflammatory dermatoses, infections and drug eruptions are the most common skin conditions in hospitalized cancer patients. ( 29273489 )
2017
23
Common Skin Conditions in Children: Foreword. ( 28196315 )
2017
24
Dermoscopy, Confocal Microscopy and other Non-invasive Tools for the Diagnosis of Non-Melanoma Skin Cancers and Other Skin Conditions. ( 28676883 )
2017
25
Common Skin Conditions in Children: Skin Infections. ( 28196318 )
2017
26
Skin conditions in veterinarians and veterinary workers: A worksite-based study. ( 27088939 )
2016
27
Is education enough to improve quality of life in people with chronic inflammatory skin conditions? ( 27317274 )
2016
28
Spirituality and mood pathology in severe skin conditions: a prospective observational study. ( 27377294 )
2016
29
Skin conditions in children. ( 27180500 )
2016
30
The epidemiology of skin conditions in the aged: A systematic review. ( 27161662 )
2016
31
Surgical Reconstruction of Traumatic Partial Ear Defects Based on a Novel Classification of Defect Sizes and Surrounding Skin Conditions. ( 27465192 )
2016
32
Skin conditions in veterinarians and veterinary workers: A worksite-based study. ( 26858051 )
2016
33
Systematic mapping review about costs and economic evaluations of skin conditions and diseases in the aged. ( 27544020 )
2016
34
Age-Associated Skin Conditions and Diseases: Current Perspectives and Future Options. ( 26994263 )
2016
35
Education to improve quality of life of people with chronic inflammatory skin conditions: a systematic review of the evidence. ( 26833102 )
2016
36
Six years' experience of grenz ray therapy for the treatment of inflammatory skin conditions. ( 27747909 )
2016
37
Treating skin conditions in the community: know your emollients. ( 27594060 )
2016
38
Physiological and microbiological verification of the benefit of hair washing in patients with skin conditions of the scalp. ( 27229771 )
2016
39
Cocoa Flavanol Supplementation Influences Skin Conditions of Photo-Aged Women: A 24-Week Double-Blind, Randomized, Controlled Trial. ( 26581682 )
2016
40
Skin conditions in a South African tuberculosis hospital: Prevalence, description, and possible associations. ( 27419379 )
2016
41
Parental, child, and adolescent experience of chronic skin conditions: A meta-ethnography and review of the qualitative literature. ( 27768987 )
2016
42
Quality of life impact of childhood skin conditions measured using the Children's Dermatology Life Quality Index (CDLQI): a meta-analysis. ( 26686685 )
2016
43
Implicit stigmatization-related biases in individuals with skin conditions and their significant others. ( 27505208 )
2016
44
Inflammatory Skin Conditions Associated With Radiotherapy. ( 28010872 )
2016
45
Fernblock (Polypodium leucotomos Extract): Molecular Mechanisms and Pleiotropic Effects in Light-Related Skin Conditions, Photoaging and Skin Cancers, a Review. ( 27367679 )
2016
46
Occupational Skin Conditions in the Emerging US Green Collar Workforce. ( 27172317 )
2016
47
Data on medicinal plants used in Central America to manage diabetes and its sequelae (skin conditions, cardiovascular disease, kidney disease, urinary problems and vision loss). ( 27761504 )
2016
48
Phototherapy for sclerosing skin conditions. ( 27638441 )
2016
49
Topical pine tar: History, properties and use as a treatment for common skin conditions. ( 26790564 )
2016
50
A glossary of terms to assist the recognition and diagnosis of skin conditions associated with lower-limb chronic oedema. ( 25950393 )
2015

Variations for Skin Conditions

Expression for Skin Conditions

Search GEO for disease gene expression data for Skin Conditions.

Pathways for Skin Conditions

GO Terms for Skin Conditions

Cellular components related to Skin Conditions according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.43 IFNK IGFL1 IGFL2 IGFL3 IL1A TNF
2 extracellular region GO:0005576 9.17 DCD IFNK IGFL1 IGFL2 IGFL3 IL1A

Biological processes related to Skin Conditions according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 humoral immune response GO:0006959 9.26 IFNK TNF
2 positive regulation of interleukin-6 production GO:0032755 9.16 IL1A TNF
3 negative regulation of extrinsic apoptotic signaling pathway in absence of ligand GO:2001240 8.96 IL1A TNF
4 positive regulation of cytokine secretion GO:0050715 8.62 IL1A TNF

Molecular functions related to Skin Conditions according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 8.8 IFNK IL1A TNF

Sources for Skin Conditions

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....